Get the Stockscreener App
3.31
11.26%
-0.42
After Hours:
3.37
0.06
+1.81%
Telomir Pharmaceuticals Inc stock is traded at $3.31, with a volume of 115.02K.
It is down -11.26% in the last 24 hours and down -29.57% over the past month.
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.
See More
Previous Close:
$3.73
Open:
$3.75
24h Volume:
115.02K
Relative Volume:
0.86
Market Cap:
$110.44M
Revenue:
-
Net Income/Loss:
$-13.08M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-24.43%
1M Performance:
-29.57%
6M Performance:
-46.44%
1Y Performance:
+0.00%
1-Day Range:
$3.30
$3.81
1-Week Range:
$3.30
$4.54
52-Week Range:
$3.11
$20.72
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
Name
Telomir Pharmaceuticals Inc
Sector
Industry
Phone
-
Address
-
Compare TELO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| TELO | 3.31 | 110.44M | 0 | -13.08M | 0 | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Telomir Pharmaceuticals Inc Stock (TELO) Latest News
Comparing Bionomics (NASDAQ:BNOX) and Telomir Pharmaceuticals (NASDAQ:TELO) - Defense World
Telomir Pharmaceuticals (NASDAQ:TELO) Trading Up 3.8%Here's Why - MarketBeat
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Sees Large Growth in Short Interest - MarketBeat
How the (TELO) price action is used to our Advantage - Stock Traders Daily
Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) last week's 12% decline must have disappointed retail investors who have a significant stake - Simply Wall St
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Shares Purchased by Beaird Harris Wealth Management LLC - Defense World
Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss ... - Moscow-Pullman Daily News
Telomir Pharmaceuticals secures $5 million funding option - Investing.com
Telomir Pharmaceuticals secures $5 million funding option By Investing.com - Investing.com Australia
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Sees Large Decrease in Short Interest - MarketBeat
Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday - AccessWire
(TELO) Investment Report - Stock Traders Daily
Telomir Pharmaceuticals, Inc. announced that it has received $5 million in funding - Marketscreener.com
Telomir Pharmaceuticals Inc (TELO) Stock: A Year of Market Fluctuations - The InvestChronicle
Financial Contrast: Telomir Pharmaceuticals (NASDAQ:TELO) & Sonnet BioTherapeutics (NASDAQ:SONN) - Defense World
Telomir Pharmaceuticals Insider Ups Holding During Year - Yahoo Finance
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Sees Significant Increase in Short Interest - MarketBeat
Telomir Pharmaceuticals (NASDAQ:TELO) Trading Up 2.2% - Defense World
Telomir Pharmaceuticals (NASDAQ:TELO) Trading 2.2% Higher - MarketBeat
Golf-Woods undergoes successful back surgery in Florida - Investing.com
Three biotechs raise $700M in rare burst of IPO activity - BioPharma Dive
What Is Going On With AST SpaceMobile Stock? - Barchart
Experience The Future Of Smart Living With Hisense At IFA 2024 - Barchart
Boeing's troubled space capsule ends mission with a landing in the New Mexico desert, leaving two astronauts in orbit - Barchart
Stakeholder In Trump's Truth Social Parent Company Wins Court Ruling Over Share Transfer - Barchart
Press'd Sandwiches Celebrates Grand Opening of New Kildonan Winnipeg Location with FREE Sandwiches - Barchart
Is RTX Corporation Stock Outperforming The S&P 500? - Barchart
US Hiring Rebounds Slightly And Unemployment Rate Dips In Sign Of Still-Slowing Job Market - Barchart
Telegram CEO Defends Himself Against French Charges In First Public Comments - Barchart
New Mexico attorney general sues company behind Snapchat alleging child sexual extortion on the site - Barchart
IGM FINANCIAL INC. ANNOUNCES AUGUST 2024 ASSETS UNDER MANAGEMENT & ADVISEMENT AND NET FLOWS - Barchart
MEDIA ADVISORYNICHI, Minister Anandasangaree, and Minister Ien to make a housing announcement in Toronto - Barchart
Media AdvisoryPrime Minister's Itinerary For Friday, September 6, 2024 - Barchart
ALIMENTATION COUCHE-TARD INC. ANNOUNCES ELECTION OF DIRECTORS - Barchart
With Musk's X Banned In Brazil, Its Users Carve Out New Digital Homes - Barchart
Telomir Pharmaceuticals’ Age Reversal Drug Shows Promise in Canine Study - Vancity Buzz
Obesity Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Novo Nordisk, Boehringer Ingelheim, Pfizer, BioAge Labs, Aphaia Pharma, Neothetics, NovMetaPharma, Carmot - Barchart
Applications For US Jobless Benefits Fall To 2-Month Low As Layoffs Remain At Healthy Levels - Barchart
WCAS Completes Acquisition Of EquiLend - Barchart
Telomir Pharmaceuticals (NASDAQ: TELO) Featured In Local ABC Exclusive Showing Positive Outcomes Of Proposed Age Reversal Pill In Dogs | FinancialContent Business Page - Financial Content
Soft Tissue Sarcoma Market is expected to grow at a significant CAGR, DelveInsight | Advenchen Laboratories, Philogen, Gradalis, Epizyme, Chugai Pharma France, CytRx, Taiho Pharmaceuticals, KaryoPharm - Barchart
FuelCell Energy: Fiscal Q3 Earnings Snapshot - Barchart
Telomir Pharmaceuticals (NASDAQ: TELO) Featured In Local ABC Exc - News Channel Nebraska
Telomir names Dr. Itzchak Angel as Chief Scientific Advisor - Investing.com
Unusual Activity In Block Inc. OptionsHighlights SQ Stock's Value - Barchart
Telomir names Dr. Itzchak Angel as Chief Scientific Advisor By Investing.com - Investing.com Canada
Protecting Homeowners From Unnecessary Financial Stress - Barchart
US Job Openings Fall As Demand For Workers Cools - Barchart
Telomir Pharmaceuticals recruits ex-Synthelabo executive By Investing.com - Investing.com Australia
Amyotrophic Lateral Sclerosis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Amylyx Pharma, Ionis Pharma, Annexon, Inc., UniQure Biopharma, Sangamo Therapeutics - Barchart
Corn Hovering Close To Unchanged To Start Wednesday - Barchart
Telomir Pharmaceuticals Inc Stock (TELO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):